Summarized by Daily Strand AI from peer-reviewed source
Doctors have long known that screening for colorectal cancer saves lives, but researchers recently set out to understand exactly how repeated invitations for stool tests affect cancer rates over time. The study looked at two common noninvasive options: the guaiac-based fecal occult blood test and the newer fecal immunochemical test, both of which look for hidden blood in the stool. Researchers followed more than 364,000 residents in a specific region of Sweden, tracking them through their 60s when they were actively invited to screen, and into their early 70s after routine screening ended.
During the active screening years between ages 60 and 69, cancer diagnoses actually went up among those who received regular invitations. Rather than being a cause for alarm, this spike simply reflects the success of early detection. By catching tumors sooner, doctors can treat them before they become an immediate threat. The real payoff appeared later on. When the researchers looked at the years following the screening period, between ages 70 and 73, they found that new cancer diagnoses dropped significantly.
In fact, the drop in later cancer cases was directly proportional to the number of screening invitations a person had received. The greatest reductions occurred in people who were invited to take five successive tests over the years. Importantly, this long-term drop in cancer rates applied to both early and advanced stages of the disease. The researchers do note a few caveats. The study focused exclusively on a regional population in Sweden, and it only tracked people for a brief window after screening ended, which means the exact results might not perfectly generalize to broader global populations.
For public health officials and medical professionals, this research underscores the immense value of persistence. Sending repeated reminders for simple, at-home stool tests actively prevents people from developing both early and advanced stages of colorectal cancer later in life. By proving that more screening invitations lead to fewer eventual cancer cases, these findings provide a clear blueprint for healthcare systems trying to design better preventive care programs.
As healthcare providers look to build more effective, risk-based screening strategies, this data offers hard evidence that consistent patient outreach works. While invasive procedures like colonoscopies are often viewed as the gold standard, demonstrating the long-term effectiveness of highly accessible stool tests could help medical systems allocate resources more efficiently, lower costs, and reach large patient populations who might otherwise avoid screening altogether.
Interested in Diagnostics?
Newsletter
Never miss a breakthrough.
Join 10,000+ curious minds getting biotech stories distilled into plain language. Free, three times a week.